Hyundai Bioscience

048410.KQ

3.44 USD

-0.14

-3.91%

Overview

Last close

3.44 usd

Market cap

330.46M usd

52 week high

7.58 usd

52 week low

3.17 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

258.373

Price/Book Value

4.4724

Enterprise Value

329.50M usd

EV/Revenue

257.0805

EV/EBITDA

-64.6317

Key financials

Revenue TTM

1.28M usd

Gross Profit TTM

53787.56 usd

EBITDA TTM

-9.80M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

88.53M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.